COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 1084: Articles 10831-10840  | Next

Baseline hypocapnia is associated with intubation in COVID-19 diagnosed patients
Gounidis, A., Evangeliou, A., Kloura, C., Magganari, E., Parisi, C., Kourtidis, M., Apostolopoulou, M., Kotronis, G., Apostolidou Kiouti, F.
10.1101/2021.11.19.21266581 — Posted: 2021-11-21
COVID-19 cases and hospitalizations averted by case investigation and contact tracing in the United States
Rainisch, G., Jeon, S., Pappas, D., Spencer, K., Fischer, L. S., Adhikari, B., Taylor, M., Greening, B., Moonan, P., Oeltmann, J., Kahn, E. B., Washington, M., Meltzer, M. I.
10.1101/2021.11.19.21266580 — Posted: 2021-11-21
Healthcare workers benefit from second dose of COVID-19 mRNA vaccine: Effects of partial and full vaccination on sick leave duration and symptoms
Strum, E. M., Casagrande, Y., Newton, K. I., Unger, J. B.
10.1101/2021.11.17.21266479 — Posted: 2021-11-21
COVID-19 Vaccine Rollouts and the Reproduction of Urban Spatial Inequality: Disparities Within Large U.S. Cities in March and April 2021 by Racial/Ethnic and Socioeconomic Composition
DiRago, N. V., Li, M., Tom, T., Schupmann, W., Carrillo, Y., Carey, C. M., Gaddis, S. M.
10.1101/2021.11.19.21266593 — Posted: 2021-11-21
Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil
Ferreira, L. S., de Almeida, G. B., Borges, M. E., Simon, L. M., Poloni, S., Bagattini, A. M., da Rosa, M. Q. M., Filho, J. A. F. D., Kuchenbecker, R. d. S., Camey, S. A., Kraenkel, R. A., Coutinho, R. M., Toscano, C. M.
10.1101/2021.11.19.21266590 — Posted: 2021-11-21
Krebs von den Lungen 6 levels in COVID-19 ICU Patients are Associated with Mortality
Scarpati, G., Baldassarre, D., Lacava, G., Oliva, F., Pascale, G., Boffardi, M., Pagliano, P., Calabrese, V., Tripepi, G., Piazza, O.
10.1101/2021.11.17.21266464 — Posted: 2021-11-21
Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: comparison of 40 mg o.d. vs 40 mg b.i.d. The X-COVID19 Randomized Clinical Trial
Morici, N., Podda, G. M., Birocchi, S., Bonacchini, L., Merli, M., Trezzi, M., Massaini, G., Agostinis, M., Carioti, G., Serino, F. S., Gazzaniga, G., Barberis, D., Antolini, L., Valsecchi, M. G., Cattaneo, M.
10.1101/2021.11.17.21266488 — Posted: 2021-11-21
Healthcare workers' SARS-CoV-2 infection rates during the second wave of the pandemic: prospective cohort study
Wurtz, A. M., Kinnerup, M. B., Pugdal, K., Schlunssen, V., Vestergaard, J. M., Nielsen, K., Cramer, C., Bonde, J. P., Biering, K., Carstensen, O., Hansen, K. K., Dalboege, A., Flachs, E. M., Hansen, M. L., Thulstrup, A. M., Wurtz, E. T., Kjaersgaard, M., Christensen, M. W., Kolstad, H. A.
10.1101/2021.11.17.21266459 — Posted: 2021-11-21
SARS-CoV-2 testing in the community: Testing positive samples with the TaqMan SARS-CoV-2 Mutation Panel to find variants in real-time
Ashford, F., Best, A., Dunn, S., Ahmed, Z., Siddiqui, H., Melville, J., Wilkinson, S., Mirza, J., Cumley, N., Stockton, J., Ferguson, J., Wheatley, L., Ratcliffe, E., Casey, A., The COVID-19 Genomics UK (COG-UK) Consortium5, , Quick, J., Richter, A., Loman, N. J., McNally, A.
10.1101/2021.11.17.21266297 — Posted: 2021-11-21
Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America
Gutierrez, B., Castelan, H. G., da Silva Candido, D., Jackson, B., Fleishon, S., Ruis, C., Delaye, L., Rambaut, A., Pybus, O., Escalera-Zamudio, M.
10.1101/2021.11.19.21266601 — Posted: 2021-11-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).